Kieserite_[as_monohydrate]

Category

Kieserite_[as_monohydrate]




Useful info

Kieserite_[as_monohydrate] Brand names, Kieserite_[as_monohydrate] Analogs

Kieserite_[as_monohydrate] Brand Names Mixture

  • No information avaliable
  • Kieserite_[as_monohydrate] Chemical_Formula

    C43H68ClNO11

    Kieserite_[as_monohydrate] RX_link

    http://www.rxlist.com/cgi/generic/elidel.htm

    Kieserite_[as_monohydrate] fda sheet

    Kieserite_[as_monohydrate] FDA

    Kieserite_[as_monohydrate] msds (material safety sheet)

    Kieserite_[as_monohydrate] Synthesis Reference

    No information avaliable

    Kieserite_[as_monohydrate] Molecular Weight

    810.453 g/mol

    Kieserite_[as_monohydrate] Melting Point

    No information avaliable

    Kieserite_[as_monohydrate] H2O Solubility

    No information avaliable

    Kieserite_[as_monohydrate] State

    Solid

    Kieserite_[as_monohydrate] LogP

    5.099

    Kieserite_[as_monohydrate] Dosage Forms

    Cream

    Kieserite_[as_monohydrate] Indication

    For treatment of mild to moderate atopic dermatitis.

    Kieserite_[as_monohydrate] Pharmacology

    Pimecrolimus is a chemical that is used to treat atopic dermatitis (eczema). Atopic dermatitis is a skin condition characterized by redness, itching, scaling and inflammation of the skin. The cause of atopic dermatitis is not known; however, scientists believe that it may be due to activation of the immune system by various environmental or emotional triggers. Scientists do not know exactly how pimecrolimus reduces the manifestations of atopic dermatitis, but pimecrolimus reduces the action of T-cells and mast cells which are part of the immune system and contribute to responses of the immune system. Pimecrolimus prevents the activation of T-cells by blocking the effects of chemicals (cytokines) released by the body that stimulate T-cells. Pimecrolimus also reduces the ability of mast cells to release chemicals that promote inflammation.

    Kieserite_[as_monohydrate] Absorption

    Because of the low systemic absorption of pimecrolimus following topical application the calculation of standard pharmacokinetic measures such as AUC, Cmax, half-life, etc. cannot be reliably done.

    Kieserite_[as_monohydrate] Toxicity

    Side effects include burning sensation, irritation, pruritus, erythema, and skin infections, at the application site.

    Kieserite_[as_monohydrate] Patient Information

    Kieserite_[as_monohydrate] Organisms Affected

    Humans and other mammals